CLB Core Laboratories Inc. /DE/

CLB financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1958086 Exchange: NYSE SIC: 1389 (Oil & Gas Field Services, NEC) Latest filing: 10-Q filed Jul 30, 2026 Data checked: Oct 21, 2026
Showing 3 of 5 annual and 0 of 16 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$498.91M (Jun 2025)
Industry (SIC)
1389 Oil & Gas Field Services, NEC
Incorporated
DE
Fiscal Year End
December (1231)
Phone
713-328-2673
EIN
000000000
Headquarters
HOUSTON, TX, 77040
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: Core Laboratories Luxembourg S.A. (2023–2023)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$519.18M
Net Income
$24.35M
Total Assets
$586.78M
Total Equity
$278.77M
Total Debt
-
Free Cash Flow
$15.14M
Ratios
Gross Margin
19.5%
Operating Margin
9.2%
Net Margin
4.7%
Return on Equity
8.7%
Return on Assets
4.2%
Current Ratio
2.12x
FCF / Assets
2.6%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Core Laboratories Inc. /DE/ generated $526.52M of revenue in fiscal 2025, with net income of $29.67M and an operating cash inflow of $37.03M. The $526.52M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. The top line expanded 0.5% from $523.85M in fiscal 2024, increasing the company’s operating scale. The company reported diluted EPS of $0.63, adding a shareholder-level measure to the absolute income figures considered below. The per-share result recorded a 4.5% decrease from fiscal 2024 diluted EPS of $0.66. Revenue equaled 0.9x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

After reported cost of revenue, the company retained $108.93M as gross profit before recognizing operating expenses and other items. Gross profit represented 20.7% of revenue, showing how much of the top line remained after direct costs. The reported operating result was $56.47M, capturing profitability after direct costs and the operating expenses reflected in the statements. Relative to revenue, operating income represented 10.7%, showing how efficiently sales converted into operating profit. After all reported below-operating-line items, the company recorded net income of $29.67M for the fiscal year. Measured against reported revenue, net income produced a 5.6% margin after operating costs and the remaining recognized items. Pretax income was $45.90M, isolating the reported earnings outcome before the income-tax provision recognized for the fiscal year. Measured against revenue, pretax income equaled 8.7%, adding a pre-tax profitability layer between revenue and net income. The company recognized $15.51M of income tax for the period, completing the transition from pretax income to net income. The effective relationship between income tax and positive pretax income was 33.8%, without assuming a statutory-rate comparison.

Liquidity and Capital Structure

Total assets were $584.01M, supported by $311.80M of liabilities and $272.21M of shareholder equity. At period end, current assets of $214.66M compared with current liabilities of $106.02M, defining the company’s short-term resource position. Current assets covered current liabilities by 2.02x, leaving a positive buffer for near-term obligations. The company held $22.70M in cash and equivalents, a narrower liquidity measure than total current assets. Measured only with cash and equivalents, coverage of current liabilities was 21.4%, excluding receivables and other current assets. Borrowings totaled $110.25M, adding a fixed financing obligation alongside the company’s equity capital. Against book equity, debt measured 0.41x, placing the company’s financial leverage in clear balance-sheet terms. Relative to total assets, debt measured 18.9%, showing how much of the asset base was matched by borrowing. Relative to total assets, liabilities measured 53.4%, complementing the separate equity-based view of the company’s capital structure. Cash and equivalents equaled 3.9% of total assets, showing the liquid cash component within the company’s broader resource base. Total assets were 1.1% lower than fiscal 2024 assets of $590.41M, measuring the company’s own balance-sheet change.

Cash Flow and Earnings Quality

The company reported $37.03M of operating cash flow, a cash inflow that shows the cash generated by operations. The operating-cash-flow-to-net-income relationship was 1.25x, comparing cash generated by operations with the bottom-line earnings result. Capital expenditures used $11.21M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Relative to operating cash flow, capital expenditures measured 30.3%, connecting investment intensity with the company’s cash-generation base. Free cash flow came to $25.82M, leaving a positive amount after capital expenditures. Free cash flow represented 4.9% of revenue, linking post-investment cash generation with the company’s operating scale. Free cash flow equaled 4.4% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Core Laboratories Inc. /DE/
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $526.52M $523.85M $509.79M
Cost of Revenue $417.59M $420.52M $399.96M
Gross Profit $108.93M $103.33M $109.83M
OPERATING EXPENSES
SG&A Expense $45.43M $39.77M $40.26M
Operating Income $56.47M $58.56M $54.64M
NON-OPERATING INCOME / EXPENSE
Interest Expense $10.57M $12.37M $13.43M
Other Income/Expense $7.61M $9.95M $850.00K
Pretax Income $45.90M $46.19M $41.21M
Income Tax $15.51M $14.03M $4.19M
Net Income $29.67M $31.40M $36.68M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.63 $0.66 $0.77
Diluted Shares 47.03M 47.69M 47.52M
EBITDA $71.12M $73.51M $70.42M
Depreciation & Amortization $14.65M $14.95M $15.78M
Balance Sheet
ASSETS
Cash & Equivalents $22.70M $19.16M $15.12M
Accounts Receivable $113.53M $111.76M $109.35M
Inventory $54.50M $59.40M $71.70M
Other Current Assets $6.94M $10.52M $5.09M
Current Assets $214.67M $226.61M $223.14M
PP&E (Net) $99.45M $97.06M $99.63M
Goodwill $105.79M $99.45M $99.45M
Intangible Assets $7.12M $6.40M $6.93M
Other Noncurrent Assets $35.26M $34.79M $34.22M
Noncurrent Assets $369.35M $363.80M $363.26M
Total Assets $584.01M $590.41M $586.40M
LIABILITIES
Accounts Payable $37.28M $34.55M $33.51M
Other Current Liabilities $16.68M $8.16M $7.65M
Current Liabilities $106.02M $97.59M $88.10M
Long-term Debt $110.26M $126.11M $163.13M
Other Noncurrent Liabilities $15.85M $20.73M $20.04M
Noncurrent Liabilities $205.79M $235.08M $268.49M
Total Liabilities $311.80M $332.67M $356.59M
EQUITY
Common Stock $470.00K $470.00K $469.00K
Additional Paid-in Capital $110.25M $109.55M $110.01M
Retained Earnings $172.66M $150.28M $120.76M
Accumulated OCI $-5.81M $-5.77M $-4.97M
Total Equity $272.21M $257.74M $229.81M
Total Liabilities & Equity $584.01M $590.41M $586.40M
SUPPLEMENTAL
Shares Outstanding 46.10M 46.83M 46.86M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $37.03M $56.39M $24.79M
Capital Expenditures $11.21M $11.89M $10.58M
Cash from Investing $-2.23M $-6.39M $-6.65M
Cash from Financing $-31.26M $-45.96M $-18.45M
Free Cash Flow $25.82M $44.50M $14.21M
Beginning Cash (CFS) $19.16M $15.12M $15.43M
Net Change in Cash $3.55M $4.04M $-308.00K
Effect of FX on Cash - - -
Calculated Ending Cash $22.70M $19.16M $15.12M
Cash per BS $22.70M $19.16M $15.12M
Cash scope difference (CFS − BS) - - -
Cash per CFS $22.70M $19.16M $15.12M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Core Laboratories Inc. /DE/'s annual revenue?

Core Laboratories Inc. /DE/ reported $519.18M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Core Laboratories Inc. /DE/ profitable?

Yes. Core Laboratories Inc. /DE/ reported $24.35M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does Core Laboratories Inc. /DE/ generate free cash flow?

Yes. Free cash flow was $15.14M for trailing twelve months. Operating cash flow was $28.22M.